Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**High mobility group box 3 pseudogene 23 (HMGB3P23)** is a human pseudogene located on chromosome 9p21, classified as a processed, retrotransposed duplicate derived from the parental HMGB3 gene[1][7][8]. As a pseudogene, HMGB3P23 does not encode a functional protein and is generally considered genomically inactive. Pseudogenes can sometimes be transcribed into non-coding RNAs that might exert regulatory effects, but currently, there is no published evidence for specific biological activity or disease association for HMGB3P23[5][8]. It is not considered a therapeutic target, receptor, or druggable entity in biomedical research, and there are no known drugs or diagnostic markers associated with this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group box 3 pseudogene 23 (HMGB3P23).